30 results on '"Xiong, Hualong"'
Search Results
2. Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels
3. Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters
4. Risedronate-functionalized manganese-hydroxyapatite amorphous particles: A potent adjuvant for subunit vaccines and cancer immunotherapy
5. Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants.
6. Micronanoparticled risedronate exhibits potent vaccine adjuvant effects
7. A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode
8. A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
9. Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD.
10. Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD
11. Risedronate-Functionalized Manganese-Calcium Phosphate Nanoparticles: A Potent Adjuvant for Subunit Vaccines and Cancer Immunotherapy
12. Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine
13. Intranasal delivery of NS1-deleted influenza virus vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response
14. New discovery of high-affinity SARS-CoV-2 spike S2 protein binding peptide selected by PhIP-Seq
15. Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines
16. The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
17. Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage
18. Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19
19. Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron
20. A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice
21. A high potent synthetic nanobody with broad-spectrum activity neutralizes SARS-Cov-2 virus and Omicron variant through a unique binding mode
22. Additional file 1 of A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode
23. Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19
24. A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters
25. Quantatitive Analysis of Conserved Sites on the SARS-CoV-2 Receptor-Binding Domain to Promote Development of Universal SARS-Like Coronavirus Vaccines
26. Preparation and functional evaluation of monoclonal antibodies targeting Hepatitis B Virus Polymerase
27. Sterilizing immunity against SARS-CoV-2 in hamsters conferred by a novel recombinant subunit vaccine
28. Virus‐Free and Live‐Cell Visualizing SARS‐CoV‐2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors
29. SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates
30. Virus‐Free and Live‐Cell Visualizing SARS‐CoV‐2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.